Literature DB >> 26409277

RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.

Carol D Hamilton1, Soumya Swaminathan2, Devasahayam J Christopher3, Jerrold Ellner4, Amita Gupta5, Timothy R Sterling6, Valeria Rolla7, Sudha Srinivasan8, Muhammad Karyana9, Sophia Siddiqui10, Sonia K Stoszek11, Peter Kim8.   

Abstract

Progress in tuberculosis clinical research is hampered by a lack of reliable biomarkers that predict progression from latent to active tuberculosis, and subsequent cure, relapse, or failure. Regional Prospective Observational Research in Tuberculosis (RePORT) International represents a consortium of regional cohorts (RePORT India, RePORT Brazil, and RePORT Indonesia) that are linked through the implementation of a Common Protocol for data and specimen collection, and are poised to address this critical research need. Each RePORT network is designed to support local, in-country tuberculosis-specific data and specimen biorepositories, and associated research. Taken together, the expected results include greater global clinical research capacity in high-burden settings, and increased local access to quality data and specimens for members of each network and their domestic and international collaborators. Additional networks are expected to be added, helping to spur tuberculosis treatment and prevention research around the world.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  biological markers; biological specimen banks; prospective studies; specimen handling; tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26409277      PMCID: PMC4583572          DOI: 10.1093/cid/civ611

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Authors:  Payam Nahid; Jussi Saukkonen; William R Mac Kenzie; John L Johnson; Patrick P J Phillips; Janet Andersen; Erin Bliven-Sizemore; John T Belisle; W Henry Boom; Annie Luetkemeyer; Thomas B Campbell; Kathleen D Eisenach; Richard Hafner; Jeffrey L Lennox; Mamodikoe Makhene; Susan Swindells; M Elsa Villarino; Marc Weiner; Constance Benson; William Burman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

2.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

3.  Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; E S Daar; M S Simberkoff; J D Hamilton
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors:  Timothy R Sterling; M Elsa Villarino; Andrey S Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E Weis; Marc Weiner; Diane Wing; Marcus B Conde; Lorna Bozeman; C Robert Horsburgh; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

5.  Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.

Authors:  Debra Benator; Mondira Bhattacharya; Lorna Bozeman; William Burman; Antonino Cantazaro; Richard Chaisson; Fred Gordin; C Robert Horsburgh; James Horton; Awal Khan; Christopher Lahart; Beverly Metchock; Constance Pachucki; Llewellyn Stanton; Andrew Vernon; M Elsa Villarino; Yong Chen Wang; Marc Weiner; Stephen Weis
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

Review 6.  Tuberculosis biomarkers discovery: developments, needs, and challenges.

Authors:  Robert S Wallis; Peter Kim; Stewart Cole; Debra Hanna; Bruno B Andrade; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

Review 7.  Diagnostic and management challenges for childhood tuberculosis in the era of HIV.

Authors:  B J Marais; S M Graham; M F Cotton; N Beyers
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

  7 in total
  18 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

2.  Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.

Authors:  Lauren S Peetluk; Peter F Rebeiro; Marcelo Cordeiro-Santos; Afranio Kritski; Bruno B Andrade; Betina Durovni; Solange Calvacante; María B Arriaga; Megan M Turner; Marina C Figueiredo; Valeria C Rolla; Timothy R Sterling
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

3.  Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.

Authors:  Carolina Geadas; Sonia K Stoszek; David Sherman; Bruno B Andrade; Sudha Srinivasan; Carol D Hamilton; Jerrold Ellner
Journal:  Tuberculosis (Edinb)       Date:  2016-11-27       Impact factor: 2.973

4.  Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.

Authors:  Akshay Gupte; Chandrasekaran Padmapriyadarsini; Vidya Mave; Dileep Kadam; Nishi Suryavanshi; Shri Vijay Bala Yogendra Shivakumar; Rewa Kohli; Nikhil Gupte; Kannan Thiruvengadam; Anju Kagal; Sushant Meshram; Renu Bharadwaj; Sandhya Khadse; Geetha Ramachandran; Luke Elizabeth Hanna; Neeta Pradhan; N S Gomathy; Andrea DeLuca; Amita Gupta; Soumya Swaminathan
Journal:  BMJ Open       Date:  2016-02-25       Impact factor: 2.692

5.  Predictors of delayed care seeking for tuberculosis in southern India: an observational study.

Authors:  Sarah E Van Ness; Ankit Chandra; Sonali Sarkar; Jane Pleskunas; Jerrold J Ellner; Gautam Roy; Subitha Lakshminarayanan; Swaroop Sahu; C Robert Horsburgh; Helen E Jenkins; Natasha S Hochberg
Journal:  BMC Infect Dis       Date:  2017-08-15       Impact factor: 3.090

6.  Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.

Authors:  Natasha S Hochberg; Sonali Sarkar; C Robert Horsburgh; Selby Knudsen; Jane Pleskunas; Swaroop Sahu; Rachel W Kubiak; S Govindarajan; Padmini Salgame; Subitha Lakshminarayanan; Amsaveni Sivaprakasam; Laura F White; Noyal Maria Joseph; Jerrold J Ellner; Gautam Roy
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

7.  Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil.

Authors:  María B Arriaga; Gustavo Amorim; Artur T L Queiroz; Moreno M S Rodrigues; Mariana Araújo-Pereira; Betania M F Nogueira; Alexandra Brito Souza; Michael S Rocha; Aline Benjamin; Adriana S R Moreira; Jamile G de Oliveira; Marina C Figueiredo; Megan M Turner; Kleydson Alves; Betina Durovni; José R Lapa-E-Silva; Afrânio L Kritski; Solange Cavalcante; Valeria C Rolla; Marcelo Cordeiro-Santos; Timothy R Sterling; Bruno B Andrade
Journal:  Int J Infect Dis       Date:  2020-11-14       Impact factor: 3.623

8.  A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.

Authors:  Lauren S Peetluk; Peter F Rebeiro; Felipe M Ridolfi; Bruno B Andrade; Marcelo Cordeiro-Santos; Afranio Kritski; Betina Durovni; Solange Calvacante; Marina C Figueiredo; David W Haas; Dandan Liu; Valeria C Rolla; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 20.999

Review 9.  Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.

Authors:  Christian Lienhardt; Knut Lönnroth; Dick Menzies; Manica Balasegaram; Jeremiah Chakaya; Frank Cobelens; Jennifer Cohn; Claudia M Denkinger; Thomas G Evans; Gunilla Källenius; Gilla Kaplan; Ajay M V Kumar; Line Matthiessen; Charles S Mgone; Valerie Mizrahi; Ya-Diul Mukadi; Viet Nhung Nguyen; Anders Nordström; Christine F Sizemore; Melvin Spigelman; S Bertel Squire; Soumya Swaminathan; Paul D Van Helden; Alimuddin Zumla; Karin Weyer; Diana Weil; Mario Raviglione
Journal:  PLoS Med       Date:  2016-03-02       Impact factor: 11.069

10.  Identifying pathway modules of tuberculosis in children by analyzing multiple different networks.

Authors:  Lu Cheng; Yuling Han; Xiuxia Zhao; Xiaoli Xu; Jing Wang
Journal:  Exp Ther Med       Date:  2017-11-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.